Antiretroviral therapy (ART) coverage in Mexico has shown a consistent upward trend from 2013 to 2023, increasing from 46 units to 69 units of adult women living with HIV. The year-on-year variations highlight a positive growth trajectory, though the growth rate has decelerated over time, from a peak year-on-year increase of 12.77% in 2015 to a 2.99% increase by 2023. The Compound Annual Growth Rate (CAGR) reflects this deceleration, with a notable decline from 10.62% in 2015 to 3.18% in 2023. The projected data from 2024 to 2028 foresee a moderate growth rate, with a forecasted 5-year CAGR of 1.9%.

Future trends to watch for include:

Potential policy changes impacting ART accessibility and affordability.
Improvements in HIV diagnosis and early intervention strategies.
Evolving public health initiatives focused on HIV/AIDS awareness and prevention.